Cell Swelling, Heat, and Chemical Agonists Use Distinct Pathways for the Activation of the Cation Channel TRPV4
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Mammalian TRPC Cation Channels
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1742 (2004) 21–36 http://www.elsevier.com/locate/bba Review The mammalian TRPC cation channels Guillermo Vazquez, Barbara J. Wedel, Omar Aziz, Mohamed Trebak, James W. Putney Jr.* The Calcium Regulation Section, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, 111 TW Alexander Dr., Research Triangle Park, NC 27709, United States Received 3 August 2004; received in revised form 27 August 2004; accepted 28 August 2004 Available online 11 September 2004 Abstract Transient Receptor Potential-Canonical (TRPC) channels are mammalian homologs of Transient Receptor Potential (TRP), a Ca2+- permeable channel involved in the phospholipase C-regulated photoreceptor activation mechanism in Drosophila. The seven mammalian TRPCs constitute a family of channels which have been proposed to function as store-operated as well as second messenger-operated channels in a variety of cell types. TRPC channels, together with other more distantly related channel families, make up the larger TRP channel superfamily. This review summarizes recent findings on the structure, regulation and function of the apparently ubiquitous TRPC cation channels. Published by Elsevier B.V. Keywords: Ion channel; Calcium channel; Non-selective cation channel; TRP channel; TRPC channel; Capacitative calcium entry; Store-operated channel; Second messenger-operated channel; Inositol trisphosphate receptor; Diacylglycerol; Phospholipase C 1. Origin, classification and nomenclature of TRPCs member, the vanilloid receptor; and the TRPM family, with eight members (TRPM1–8), named after the original The recognition that the protein product derived from member, melastatin (Fig. -
Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain
1 Review 2 Clinical Implications of 20-Hydroxyeicosatetraenoic 3 Acid in the Kidney, Liver, Lung and Brain: An 4 Emerging Therapeutic Target 5 Osama H. Elshenawy 1, Sherif M. Shoieb 1, Anwar Mohamed 1,2 and Ayman O.S. El-Kadi 1,* 6 1 Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton T6G 2E1, AB, Canada; 7 [email protected] (O.H.E.); [email protected] (S.M.S.); [email protected] (A.M.) 8 2 Department of Basic Medical Sciences, College of Medicine, Mohammed Bin Rashid University of 9 Medicine and Health Sciences, Dubai, United Arab Emirates 10 * Correspondence: [email protected]; Tel.: 780-492-3071; Fax: 780-492-1217 11 Academic Editor: Kishor M. Wasan 12 Received: 12 January 2017; Accepted: 15 February 2017; Published: 20 February 2017 13 Abstract: Cytochrome P450-mediated metabolism of arachidonic acid (AA) is an important 14 pathway for the formation of eicosanoids. The ω-hydroxylation of AA generates significant levels 15 of 20-hydroxyeicosatetraenoic acid (20-HETE) in various tissues. In the current review, we discussed 16 the role of 20-HETE in the kidney, liver, lung, and brain during physiological and 17 pathophysiological states. Moreover, we discussed the role of 20-HETE in tumor formation, 18 metabolic syndrome and diabetes. In the kidney, 20-HETE is involved in modulation of 19 preglomerular vascular tone and tubular ion transport. Furthermore, 20-HETE is involved in renal 20 ischemia/reperfusion (I/R) injury and polycystic kidney diseases. The role of 20-HETE in the liver is 21 not clearly understood although it represents 50%–75% of liver CYP-dependent AA metabolism, 22 and it is associated with liver cirrhotic ascites. -
Quantification and Potential Functions of Endogenous Agonists Of
Gastroenterology 2015;149:433–444 Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome Nicolas Cenac,1,2,3 Tereza Bautzova,1,2,3 Pauline Le Faouder,1,2,3,4,5 Nicholas A. Veldhuis,6 Daniel P. Poole,6,7 Corinne Rolland,1,2,3 Jessica Bertrand,1,2,3 Wolfgang Liedtke,8 Marc Dubourdeau,9 Justine Bertrand-Michel,4,5 Lisa Zecchi,10 Vincenzo Stanghellini,10 Nigel W. Bunnett,6,11 Giovanni Barbara,10 and Nathalie Vergnolle1,2,3,12 1Inserm, U1043, Toulouse, France; 2CNRS, U5282, Toulouse, France; 3Université de Toulouse, Université Paul Sabatier, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, France; 4Inserm U1048, Toulouse, France; 5Lipidomic Core Facility, Metatoul Platform, Université de Toulouse, Université Paul Sabatier, Toulouse, France; 6Monash Institute of Pharmaceutical Sciences, Parkville, Victoria, Australia; 7Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Victoria, Australia; 8Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; 9Ambiotis SAS, Toulouse, France; 10Departments of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy; 11Department of Pharmacology, The University of Melbourne, Parkville, Victoria, Australia; and 12University of Calgary, Department of Pharmacology and Physiology, Calgary, Alberta, Canada supernatants from IBS biopsies. Levels of 5,6-EET and 15-HETE See editorial on page 287. were increased in colons of mice with, but not without, visceral hypersensitivity. PUFA metabolites extracted from IBS biopsies or colons of mice with visceral hypersensitivity activated mouse BACKGROUND & AIMS: In mice, activation of the transient sensory neurons in vitro, by activating TRPV4. -
Linoleic Acid Participates in the Response to Ischemic Brain Injury
www.nature.com/scientificreports OPEN Linoleic acid participates in the response to ischemic brain injury through oxidized metabolites that Received: 13 January 2017 Accepted: 20 April 2017 regulate neurotransmission Published: xx xx xxxx Marie Hennebelle1, Zhichao Zhang1, Adam H. Metherel2, Alex P. Kitson2, Yurika Otoki1,3, Christine E. Richardson4, Jun Yang 5, Kin Sing Stephen Lee5, Bruce D. Hammock 5, Liang Zhang6,7, Richard P. Bazinet2 & Ameer Y. Taha1 Linoleic acid (LA; 18:2 n-6), the most abundant polyunsaturated fatty acid in the US diet, is a precursor to oxidized metabolites that have unknown roles in the brain. Here, we show that oxidized LA- derived metabolites accumulate in several rat brain regions during CO2-induced ischemia and that LA- derived 13-hydroxyoctadecadienoic acid, but not LA, increase somatic paired-pulse facilitation in rat hippocampus by 80%, suggesting bioactivity. This study provides new evidence that LA participates in the response to ischemia-induced brain injury through oxidized metabolites that regulate neurotransmission. Targeting this pathway may be therapeutically relevant for ischemia-related conditions such as stroke. Omega-6 linoleic acid (LA, 18:2 n-6) is the most consumed polyunsaturated fatty acid (PUFA) in the US diet, accounting for approximately 7% of daily calories1. The consumption of its elongation-desaturation product, arachidonic acid (AA, 20:4n-6), as well as omega-3 α-linolenic acid (ALA, 18:3n-3), eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3), collectively account for less than 1% of calories. Despite being the main PUFA in the diet, little is known about the role of LA in the brain. -
TRPV Channels and Their Pharmacological Modulation
Cellular Physiology Cell Physiol Biochem 2021;55(S3):108-130 DOI: 10.33594/00000035810.33594/000000358 © 2021 The Author(s).© 2021 Published The Author(s) by and Biochemistry Published online: online: 28 28 May May 2021 2021 Cell Physiol BiochemPublished Press GmbH&Co. by Cell Physiol KG Biochem 108 Press GmbH&Co. KG, Duesseldorf SeebohmAccepted: 17et al.:May Molecular 2021 Pharmacology of TRPV Channelswww.cellphysiolbiochem.com This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Review Beyond Hot and Spicy: TRPV Channels and their Pharmacological Modulation Guiscard Seebohma Julian A. Schreibera,b aInstitute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany, bInstitut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany Key Words TRPV • Molecular pharmacology • Capsaicin • Ion channel modulation • Medicinal chemistry Abstract Transient receptor potential vanilloid (TRPV) channels are part of the TRP channel superfamily and named after the first identified member TRPV1, that is sensitive to the vanillylamide capsaicin. Their overall structure is similar to the structure of voltage gated potassium channels (Kv) built up as homotetramers from subunits with six transmembrane helices (S1-S6). Six TRPV channel subtypes (TRPV1-6) are known, that can be subdivided into the thermoTRPV 2+ (TRPV1-4) and the Ca -selective TRPV channels (TRPV5, TRPV6). Contrary to Kv channels, TRPV channels are not primary voltage gated. All six channels have distinct properties and react to several endogenous ligands as well as different gating stimuli such as heat, pH, mechanical stress, or osmotic changes. -
Ca2+ Signaling by TRPV4 Channels in Respiratory Function and Disease
cells Review Ca2+ Signaling by TRPV4 Channels in Respiratory Function and Disease Suhasini Rajan, Christian Schremmer, Jonas Weber, Philipp Alt, Fabienne Geiger and Alexander Dietrich * Experimental Pharmacotherapy, Walther-Straub-Institute of Pharmacology and Toxicology, Member of the German Center for Lung Research (DZL), LMU-Munich, 80336 Munich, Germany; [email protected] (S.R.); [email protected] (C.S.); [email protected] (J.W.); [email protected] (P.A.); [email protected] (F.G.) * Correspondence: [email protected] Abstract: Members of the transient receptor potential (TRP) superfamily are broadly expressed in our body and contribute to multiple cellular functions. Most interestingly, the fourth member of the vanilloid family of TRP channels (TRPV4) serves different partially antagonistic functions in the respiratory system. This review highlights the role of TRPV4 channels in lung fibroblasts, the lung endothelium, as well as the alveolar and bronchial epithelium, during physiological and pathophysiological mechanisms. Data available from animal models and human tissues confirm the importance of this ion channel in cellular signal transduction complexes with Ca2+ ions as a second messenger. Moreover, TRPV4 is an excellent therapeutic target with numerous specific compounds regulating its activity in diseases, like asthma, lung fibrosis, edema, and infections. Keywords: TRP channels; TRPV4; respiratory system; lung; endothelium; epithelium; Ca2+ signaling; signal transduction Citation: Rajan, S.; Schremmer, C.; Weber, J.; Alt, P.; Geiger, F.; Dietrich, A. Ca2+ Signaling by TRPV4 1. Introduction Channels in Respiratory Function and Cation selective ion channels of the transient receptor potential (TRP) superfamily con- Disease. -
Transient Receptor Potential Channels As Drug Targets: from the Science of Basic Research to the Art of Medicine
1521-0081/66/3/676–814$25.00 http://dx.doi.org/10.1124/pr.113.008268 PHARMACOLOGICAL REVIEWS Pharmacol Rev 66:676–814, July 2014 Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics ASSOCIATE EDITOR: DAVID R. SIBLEY Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine Bernd Nilius and Arpad Szallasi KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Ion Channel Research, Campus Gasthuisberg, Leuven, Belgium (B.N.); and Department of Pathology, Monmouth Medical Center, Long Branch, New Jersey (A.S.) Abstract. ....................................................................................679 I. Transient Receptor Potential Channels: A Brief Introduction . ...............................679 A. Canonical Transient Receptor Potential Subfamily . .....................................682 B. Vanilloid Transient Receptor Potential Subfamily . .....................................686 C. Melastatin Transient Receptor Potential Subfamily . .....................................696 Downloaded from D. Ankyrin Transient Receptor Potential Subfamily .........................................700 E. Mucolipin Transient Receptor Potential Subfamily . .....................................702 F. Polycystic Transient Receptor Potential Subfamily . .....................................703 II. Transient Receptor Potential Channels: Hereditary Diseases (Transient Receptor Potential Channelopathies). ......................................................704 -
Use of a Soluble Epoxide Hydrolase Inhibitor in Smoke-Induced Chronic Obstructive Pulmonary Disease
Use of a Soluble Epoxide Hydrolase Inhibitor in Smoke-Induced Chronic Obstructive Pulmonary Disease Lei Wang1, Jun Yang2, Lei Guo1, Dale Uyeminami1, Hua Dong2, Bruce D. Hammock2, and Kent E. Pinkerton1 1Center for Health and the Environment, and 2Department of Entomology and Cancer Center, University of California at Davis Medical Center, University of California at Davis, Davis, California Tobacco smoke-induced chronic obstructive pulmonary disease (COPD) is a prolonged inflammatory condition of the lungs character- CLINICAL RELEVANCE ized by progressive and largely irreversible airflow limitation attribu- table to a number of pathologic mechanisms, including bronchitis, Inflammation is provoked by inflammatory leukocytes and bronchiolitis, emphysema, mucus plugging, pulmonary hypertension, mediators thought to play a critical role in the development and small-airway obstruction. Soluble epoxide hydrolase inhibitors of chronic obstructive pulmonary disease (COPD). Soluble (sEHIs) demonstrated anti-inflammatory properties in a rat model epoxide hydrolase inhibitors were shown to possess thera- after acute exposure to tobacco smoke. We compared the efficacy peutic efficacy in the treatment and management of acute of sEHI t-TUCB (trans-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]- inflammatory disease. It is not known whether soluble ep- cyclohexyloxy}-benzoic acid) and the phosphodiesterase-4 (PDE4) oxide hydrolase inhibitors could ameliorate the pulmonary inhibitor Rolipram (Biomol International, Enzo Life Sciences, Farm- inflammation induced by -
A Proposed Common Mechanism by Which Phorbol Esters And
(CANCER RESEARCH 51, 4328-4335. August 15. I991| A Proposed Common Mechanism by Which Phorbol Esters and Epidermal Growth Factor Delay the Progression from G2 Phase to Mitosis of HeLa Cells through Phospholipid Metabolites' Marietta Kaszkin, Gerhard Fiirstenberger, James Richards, Lothar Seidler, and Volker Kinzel2 Institute of Experimental Pathology [M. K.. J. R., L. S., V. K.J and Institute of Biochemistry {G. F.], German Cancer Research Center, Im Neuenheimer Feld 280, D-6900 Heidelberg, Federal Republic of Germany ABSTRACT tumor promoters in the cell cycle of replicating cells (10) we observed a transient inhibition of the progression from G2 to The phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA; also mitosis in HeLa cells induced by phorbol esters which carries called phorbol myristate acetate) and epidermal growth factor both the characteristics of a receptor-mediated response (11). The rapidly inhibit the transition of HeLa cells from <... phase to mitosis in a results led us to suppose that physiological factors such as reversible fashion with characteristics of a receptor-mediated response. EGF3 which elicit certain comparable metabolites should induce It was proposed that an intracellular mediator was responsible for this inhibition. In searching for a common mediator elicited by the action of a transient inhibition of the G2-M transition like that of phorbol both ligands, the time course of generation of phospholipid metabolites esters. This indeed was shown for EGF (12). In order to was compared with the cell cycle response of the G2 cohort monitored by approach the transduction mechanism the attention was thus time lapse analysis. The time course and the degree of mobilization of focused on biologically active metabolites of phospholipids diacylglycerols (DC) effected by TPA and by epidermal growth factor known to be elicited by EGF and by phorbol esters. -
5696.Full.Pdf
[CANCER RESEARCH 46, 5696-5700, November 1986] Enhanced Release of Hydrogen Peroxide and Metabolites of Arachidonic Acid by Macrophages from SENCAR Mice following Stimulation with Phorbol Esters1 James G. Lewis and Dolph O. Adams Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710 ABSTRACT genotoxic ROIs,2 and lipid oxidation products (8-10). Leuko cytes stimulated with phorbol esters also suffer breakage of Chronic inflammation has long been associated with carcinogenesis. their DNA, produce soluble low molecular weight clastogenic Phorbol esters which are potent promoters of tumors in mouse skin are factors, and induce increased rates of sister chromatid exchange also potent inflammatory agents in skin and cause inflammatory cells to in cm-illtu red mammalian cells (11-14). We have shown that release large quantities of reactive oxygen intermediates and oxidized murine peritoneal macrophages, stimulated with phorbol esters lipid products. SENCAR mice have been bred for their sensitivity to the or particulate inflammatory signals, induce 5,6-ring saturated promotion of tumors by phorbol esters and CS7BL/6 mice have been thymine bases in the DNA of cocultured mammalian cells (15, shown to be resistant. We quantified the release of H2O2 and metabolites 16). This process was inhibited by both catalase and nordihy- of arachidi mic acid by macrophages obtained from SENCAR and C57BL/ droguaiaretic acid (an inhibitor of arachidonic acid metabolism) 6 mice, following exposure to phorbol esters and other stimulants. The and was enhanced by Superoxide dismutase and indomethacin basal level for secretion of 112(): in resident peritoneal macrophages was (an inhibitor specific for cyclooxygenases). -
Negative Modulation of TRPM8 Channel Function by Protein Kinase C in Trigeminal Cold Thermoreceptor Neurons
International Journal of Molecular Sciences Article Negative Modulation of TRPM8 Channel Function by Protein Kinase C in Trigeminal Cold Thermoreceptor Neurons Bastián Rivera 1 , Matías Campos 1, Patricio Orio 2 , Rodolfo Madrid 1 and María Pertusa 1,* 1 Department of Biology, Facultad de Química y Biología, Universidad de Santiago de Chile, and Millennium Nucleus of Ion Channel-Associated Diseases (MiNICAD), 9160000 Santiago, Chile; [email protected] (B.R.); [email protected] (M.C.); [email protected] (R.M.) 2 Centro Interdisciplinario de Neurociencia de Valparaíso and Instituto de Neurociencia, Facultad de Ciencias, Universidad de Valparaíso, 2360102 Valparaíso, Chile; [email protected] * Correspondence: [email protected]; Tel.: +56-2-271-82955 Received: 30 April 2020; Accepted: 12 June 2020; Published: 22 June 2020 Abstract: TRPM8 is the main molecular entity responsible for cold sensing. This polymodal ion channel is activated by cold, cooling compounds such as menthol, voltage, and rises in osmolality. In corneal cold thermoreceptor neurons (CTNs), TRPM8 expression determines not only their sensitivity to cold, but also their role as neural detectors of ocular surface wetness. Several reports suggest that Protein Kinase C (PKC) activation impacts on TRPM8 function; however, the molecular bases of this functional modulation are still poorly understood. We explored PKC-dependent regulation of TRPM8 using Phorbol 12-Myristate 13-Acetate to activate this kinase. Consistently, recombinant TRPM8 channels, cultured trigeminal neurons, and free nerve endings of corneal CTNs revealed a robust reduction of TRPM8-dependent responses under PKC activation. In corneal CTNs, PKC activation decreased ongoing activity, a key parameter in the role of TRPM8-expressing neurons as humidity detectors, and also the maximal cold-evoked response, which were validated by mathematical modeling. -
Phorbol-12,13-Dibutyrate
Phorbol-12,13-dibutyrate sc-202285 Material Safety Data Sheet Hazard Alert Code EXTREME HIGH MODERATE LOW Key: Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME Phorbol-12,13-dibutyrate STATEMENT OF HAZARDOUS NATURE CONSIDERED A HAZARDOUS SUBSTANCE ACCORDING TO OSHA 29 CFR 1910.1200. NFPA FLAMMABILITY1 HEALTH2 HAZARD INSTABILITY0 SUPPLIER Company: Santa Cruz Biotechnology, Inc. Address: 2145 Delaware Ave Santa Cruz, CA 95060 Telephone: 800.457.3801 or 831.457.3800 Emergency Tel: CHEMWATCH: From within the US and Canada: 877-715-9305 Emergency Tel: From outside the US and Canada: +800 2436 2255 (1-800-CHEMCALL) or call +613 9573 3112 PRODUCT USE Tumour-promoting compound with structural skeleton based on cyclopropabenzazulene. Phorbol myristate acetate (PMA), extracted from croton oil produced by the seeds of Croton tiglium Euphorbiaceae, is an active irritant and tumour-promoting agent. PMA is thought to be representative of the family of phorbol esters in the toxic actions it produces. Phorbol 12,13- dibutyrate is commonly used in binding studies or in applications requiring relatively high concentrations of phorbol ester because of its higher solubility in aqueous solutions than other phorbol compounds. SYNONYMS C28-H40-O8, "butanoic acid 1, 1a, 1b, 4, 4a, 5, 7a, 7b, 8, 9-decahydro-4a, 7b-dihydroxy-", 3-, "butanoic acid 1, 1a, 1b, 4, 4a, 5, 7a, 7b, 8, 9-decahydro-4a, 7b-dihydroxy-", 3-, "(hydroxymethyl)-1-tetramethyl-5-oxo-9ah-cyclopropa[3, 4]benz[1, 2-e]-", "azulene-9, 9a-diyl ester, (1ar-(1-alpha, 1b-beta, 4a-beta, 7a-alpha, 7b-", "alpha, 8-alpha, 9-beta, 9a-alpha))-", "(hydroxymethyl)-1-tetramethyl-5-oxo-9ah-cyclopropa[3, 4]benz[1, 2-e]-", "azulene-9, 9a-diyl ester, (1ar-(1-alpha, 1b-beta, 4a-beta, 7a-alpha, 7b-", "alpha, 8-alpha, 9-beta, 9a-alpha))-", PDBu, "cyclopropabenzazulene analogue" Section 2 - HAZARDS IDENTIFICATION CANADIAN WHMIS SYMBOLS EMERGENCY OVERVIEW RISK Harmful in contact with skin.